Adial pharmaceuticals to present at the 2023 jefferies global healthcare conference on june 9th

Charlottesville, va., june 01, 2023 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced today that it will be presenting at the jefferies 2023 global healthcare conference being held june 7-9, 2023, at the marriott marquis in new york, ny.
ADIL Ratings Summary
ADIL Quant Ranking